DL
Therapeutic Areas
Teclison Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TEC-001 (with TATE) | Colorectal Cancer | Phase 2 |
| TEC-001 + Opdivo | Liver Cancer (Advanced stage) | Phase 2 |
| TEC-001 + Keytruda | Lung Cancer | Phase 2 |
| TEC-002 | Solid Tumors | Preclinical |
| TEC-003 | Solid Tumors | Preclinical |